217 related articles for article (PubMed ID: 6271844)
1. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
2. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
Einhorn L
Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
[No Abstract] [Full Text] [Related]
3. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
Johansson R; Kilkku P; Groenroos M
Cancer Treat Rev; 1982 Dec; 9 Suppl B():25-33. PubMed ID: 6299551
[No Abstract] [Full Text] [Related]
5. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
6. Nabilone: an alternative antiemetic for cancer chemotherapy.
Dalzell AM; Bartlett H; Lilleyman JS
Arch Dis Child; 1986 May; 61(5):502-5. PubMed ID: 3013104
[TBL] [Abstract][Full Text] [Related]
7. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
Niiranen A; Mattson K
Am J Clin Oncol; 1985 Aug; 8(4):336-40. PubMed ID: 3002167
[TBL] [Abstract][Full Text] [Related]
8. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Davis MP
Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
[TBL] [Abstract][Full Text] [Related]
9. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
Levitt M
Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
[No Abstract] [Full Text] [Related]
10. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
Cunningham D; Forrest GJ; Soukop M; Gilchrist NL; Calder IT; McArdle CS
Br Med J (Clin Res Ed); 1985 Sep; 291(6499):864-5. PubMed ID: 2996690
[No Abstract] [Full Text] [Related]
11. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S
J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611
[TBL] [Abstract][Full Text] [Related]
12. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
Chan HS; Correia JA; MacLeod SM
Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
[TBL] [Abstract][Full Text] [Related]
13. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
Ahmedzai S; Carlyle DL; Calder IT; Moran F
Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
[TBL] [Abstract][Full Text] [Related]
14. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
Lane M; Smith FE; Sullivan RA; Plasse TF
Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391
[TBL] [Abstract][Full Text] [Related]
15. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
16. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
Jones SE; Durant JR; Greco FA; Robertone A
Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555
[No Abstract] [Full Text] [Related]
17. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
Steele N; Gralla RJ; Braun DW; Young CW
Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
[TBL] [Abstract][Full Text] [Related]
18. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
19. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
